Quest Diagnostics (DGX)

EBITDA Margin

19.26%

TTM · Period ending:

DGX logo

DGX EBITDA Margin

Latest reported19.26%
DGX TTM EBITDA Margin (-34.02% → 19.26%)
High-resolution chart · PNG

DGX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Quest Diagnostics EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
14.0334%
13.8154%
13.2152%
13.1262%
12.3398%
11.3214%
11.0141%
11.1108%
10.973%
10.9353%
11.1888%
10.4334%
10.2674%
10.2029%
9.8718%
-22.0902%
-34.019%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.